Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Steroid Taper for Chronic Rhinosinusitis

Introduction to Steroid Treatment

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends starting with oral prednisolone 25-60 mg daily for 7-14 days as the initial treatment for moderate to severe CRSwNP 1, 2
  • Alternative regimens include prednisolone 1 mg/kg daily for 2 days, then taper down until day 10 or 60 mg daily for 7 days followed by 10 mg every other day for 8-10 days 3

Oral Corticosteroid Regimen for CRSwNP

  • The benefit of oral steroids is transient—symptom improvement is significant at 2-4 weeks but disappears by 10-12 weeks after treatment initiation 1, 2
  • Polyp reduction persists slightly longer but also diminishes over time 1, 2

Transition to Long-Term Topical Therapy

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends transitioning to topical intranasal corticosteroids for sustained control immediately after the oral steroid course 4, 5, 6
  • Alternative options include mometasone furoate or budesonide at equivalent doses 4, 5

Delivery Method Matters

  • Corticosteroid drops and nasal irrigation are more effective than spray formulations for reducing polyp size and improving symptoms 4, 5
  • Bi-directional exhalation devices show better efficacy than standard sprays 4, 5

Management of CRS Without Nasal Polyps

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends topical intranasal corticosteroids as first-line therapy for CRSsNP 7, 8
  • Saline nasal irrigation is also recommended for CRSsNP 7, 8

Preoperative Use

  • Oral prednisolone 30-60 mg daily for 5-10 days preoperatively reduces blood loss, improves surgical field quality, and decreases operation time 3
  • Topical mometasone 200 μg twice daily for 4 weeks preoperatively provides similar benefits 3

Postoperative Care

  • Postoperative oral steroids show no significant benefit, and instead, topical intranasal steroids should be continued postoperatively 1, 2, 7, 8

Safety Considerations

  • Short courses of oral corticosteroids (7-21 days) can cause insomnia, mood changes, and gastrointestinal symptoms 1, 2
  • Rare but serious risks include avascular necrosis and fatal varicella-zoster infection 1, 2